Analysis: John Boozman's buy of XFIV (Unknown (unresolved ticker))
Assessment: Low signal
An unidentifiable ticker traded within an active, adviser-managed fixed-income portfolio provides no policy alignment, no catalyst, and zero directional signal.
- Member: John Boozman
- Party / state: Republican (AR)
- Chamber: Senate
- Transaction: Buy
- Amount: $50,001 - $100,000
- Ticker: XFIV
- Company: Unknown (unresolved ticker)
- Trade date: 2026-05-13
- Disclosure date: 2026-06-16
- Disclosure lag: 34 days
Executive summary
John Boozman (U.S. Senator, Republican; Agriculture Committee Chair; member of Appropriations, EPW, Rules, and Veterans’ Affairs) reported a purchase of XFIV on 2026-05-13 in the $50,001-$100,000 range (self-owned), disclosed on 2026-06-16 (34-day lag). Within the user-provided trade history, this was followed by a smaller additional XFIV purchase on 2026-05-27 and coincided with a same-day small purchase of GIGB. External context research (Congress.gov, SEC EDGAR, Federal Register, Regulations.gov, USAspending, news) could not be completed here due to access limitations and lack of issuer identification for XFIV.
Within the provided dataset (360 trades across 126 tickers from 2023-08-29 to 2026-05-27), the analyzed XFIV trade is one of only two XFIV transactions recorded, both purchases, with the initial purchase ($50,001-$100,000) materially larger than the member’s most commonly observed disclosed range ($1,001-$15,000). The trade occurred on a day when the member also purchased GIGB in a smaller range, and the member later added a smaller XFIV position on 2026-05-27. Because ticker-to-issuer identification for XFIV was not available from the inputs (and live EDGAR access was not possible here), this research could not extract issuer filings (10-K/8-K), insider Form 4 activity, Federal Register items, Regulations.gov dockets, or Congress.gov bill/hearing mentions tied to the underlying issuer/industry beyond general keyword attempts. As a result, the timeline is limited to the user-provided transaction/disclosure events and cannot include corroborating external catalysts.
Timeline
- 2026-05-13 — Purchase of XFIV ($50,001-$100,000), owner: Self.
- 2026-05-13 — Same-day purchase of GIGB ($1,001-$15,000), owner: Self.
- 2026-05-27 — Additional purchase of XFIV ($1,001-$15,000), owner: Self.
- 2026-06-16 — Disclosure filed for the 2026-05-13 XFIV purchase.
Independent analysis of public financial disclosures. Not financial or investment advice.